Now that the majority of people living with HIV take combination antiretroviral therapy (ART), the
spectrum of causes of pyrexia of unknown origin (PUO) has changed compared with the pre-ART era.
In these guidelines, we focus on causes and evaluation of PUO among people living with HIV with
CD4 counts <3...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at reducing...
In 2019, 178 new HIV cases were diagnosed in Estonia (13.5 cases per 100,000 people). Among the new cases, the proportion of women was 37%. 53% of the new cases were discovered in Tallinn and 25% in Ida-Virumaa. Between 2010 and 2019, the number of new cases per year has decreased twice, but remains very...
These guidelines provide guidance on the diagnosis of HIV infection, the care of people living
with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection.
They are structured along the continuum of HIV testing, prevention, treatment and care.
This edition updates the 201...
HIV is a chronic viral infection that damages the immune system. HIV can be contracted during sexual intercourse or through direct contact with the blood of an infected person (including sharing syringes). The virus can also be transmitted from mother to child during pregnancy, childbirth or breastfeedin...
These consolidated guidelines on HIV testing services (HTS) bring together existing and
new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in
2015, in response to requests from Member States, national programme ...
This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first...
These consolidated guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, care and treatme...
